Cargando…

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies

BACKGROUND: Patients with non‐small cell lung cancer may develop pneumonitis after thoracic radiotherapy (RT) and immune checkpoint inhibitors (ICIs). We hypothesized that distinct morphologic features are associated with different pneumonitis etiologies. MATERIALS AND METHODS: We systematically com...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuguang, Sheikh, Khadija, Nakajima, Erica, Lin, Cheng Ting, Lee, Junghoon, Hu, Chen, Hales, Russell K., Forde, Patrick M., Naidoo, Jarushka, Voong, Khinh Ranh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488797/
https://www.ncbi.nlm.nih.gov/pubmed/34251728
http://dx.doi.org/10.1002/onco.13900
_version_ 1784578231127506944
author Chen, Xuguang
Sheikh, Khadija
Nakajima, Erica
Lin, Cheng Ting
Lee, Junghoon
Hu, Chen
Hales, Russell K.
Forde, Patrick M.
Naidoo, Jarushka
Voong, Khinh Ranh
author_facet Chen, Xuguang
Sheikh, Khadija
Nakajima, Erica
Lin, Cheng Ting
Lee, Junghoon
Hu, Chen
Hales, Russell K.
Forde, Patrick M.
Naidoo, Jarushka
Voong, Khinh Ranh
author_sort Chen, Xuguang
collection PubMed
description BACKGROUND: Patients with non‐small cell lung cancer may develop pneumonitis after thoracic radiotherapy (RT) and immune checkpoint inhibitors (ICIs). We hypothesized that distinct morphologic features are associated with different pneumonitis etiologies. MATERIALS AND METHODS: We systematically compared computed tomography (CT) features of RT‐ versus ICI‐pneumonitis. Clinical and imaging features were tested for association with pneumonitis severity. Lastly, we constructed an exploratory radiomics‐based machine learning (ML) model to discern pneumonitis etiology. RESULTS: Between 2009 and 2019, 82 patients developed pneumonitis: 29 after thoracic RT, 23 after ICI, and 30 after RT + ICI. Fifty patients had grade 2 pneumonitis, 22 grade 3, and 7 grade 4. ICI‐pneumonitis was more likely bilateral (65% vs. 28%; p = .01) and involved more lobes (66% vs. 45% involving at least three lobes) and was less likely to have sharp border (17% vs. 59%; p = .004) compared with RT‐pneumonitis. Pneumonitis morphology after RT + ICI was heterogeneous, with 47% bilateral, 37% involving at least three lobes, and 40% sharp borders. Among all patients, risk factors for severe pneumonitis included poor performance status, smoking history, worse lung function, and bilateral and multifocal involvement on CT. An ML model based on seven radiomic features alone could distinguish ICI‐ from RT‐pneumonitis with an area under the receiver‐operating curve of 0.76 and identified the predominant etiology after RT + ICI concordant with multidisciplinary consensus. CONCLUSION: RT‐ and ICI‐pneumonitis exhibit distinct spatial features on CT. Bilateral and multifocal lung involvement is associated with severe pneumonitis. Integrating these morphologic features in the clinical management of patients who develop pneumonitis after RT and ICIs may improve treatment decision‐making. IMPLICATIONS FOR PRACTICE: Patients with non‐small cell lung cancer often receive thoracic radiation and immune checkpoint inhibitors (ICIs), both of which can cause pneumonitis. This study identified similarities and differences in pneumonitis morphology on computed tomography (CT) scans among pneumonitis due to radiotherapy (RT) alone, ICI alone, and the combination of both. Patients who have bilateral CT changes involving at least three lobes are more likely to have ICI‐pneumonitis, whereas those with unilateral CT changes with sharp borders are more likely to have radiation pneumonitis. After RT and/or ICI, severe pneumonitis is associated with bilateral and multifocal CT changes. These results can help guide clinicians in triaging patients who develop pneumonitis after radiation and during ICI treatment.
format Online
Article
Text
id pubmed-8488797
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-84887972021-10-08 Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies Chen, Xuguang Sheikh, Khadija Nakajima, Erica Lin, Cheng Ting Lee, Junghoon Hu, Chen Hales, Russell K. Forde, Patrick M. Naidoo, Jarushka Voong, Khinh Ranh Oncologist Lung Cancer BACKGROUND: Patients with non‐small cell lung cancer may develop pneumonitis after thoracic radiotherapy (RT) and immune checkpoint inhibitors (ICIs). We hypothesized that distinct morphologic features are associated with different pneumonitis etiologies. MATERIALS AND METHODS: We systematically compared computed tomography (CT) features of RT‐ versus ICI‐pneumonitis. Clinical and imaging features were tested for association with pneumonitis severity. Lastly, we constructed an exploratory radiomics‐based machine learning (ML) model to discern pneumonitis etiology. RESULTS: Between 2009 and 2019, 82 patients developed pneumonitis: 29 after thoracic RT, 23 after ICI, and 30 after RT + ICI. Fifty patients had grade 2 pneumonitis, 22 grade 3, and 7 grade 4. ICI‐pneumonitis was more likely bilateral (65% vs. 28%; p = .01) and involved more lobes (66% vs. 45% involving at least three lobes) and was less likely to have sharp border (17% vs. 59%; p = .004) compared with RT‐pneumonitis. Pneumonitis morphology after RT + ICI was heterogeneous, with 47% bilateral, 37% involving at least three lobes, and 40% sharp borders. Among all patients, risk factors for severe pneumonitis included poor performance status, smoking history, worse lung function, and bilateral and multifocal involvement on CT. An ML model based on seven radiomic features alone could distinguish ICI‐ from RT‐pneumonitis with an area under the receiver‐operating curve of 0.76 and identified the predominant etiology after RT + ICI concordant with multidisciplinary consensus. CONCLUSION: RT‐ and ICI‐pneumonitis exhibit distinct spatial features on CT. Bilateral and multifocal lung involvement is associated with severe pneumonitis. Integrating these morphologic features in the clinical management of patients who develop pneumonitis after RT and ICIs may improve treatment decision‐making. IMPLICATIONS FOR PRACTICE: Patients with non‐small cell lung cancer often receive thoracic radiation and immune checkpoint inhibitors (ICIs), both of which can cause pneumonitis. This study identified similarities and differences in pneumonitis morphology on computed tomography (CT) scans among pneumonitis due to radiotherapy (RT) alone, ICI alone, and the combination of both. Patients who have bilateral CT changes involving at least three lobes are more likely to have ICI‐pneumonitis, whereas those with unilateral CT changes with sharp borders are more likely to have radiation pneumonitis. After RT and/or ICI, severe pneumonitis is associated with bilateral and multifocal CT changes. These results can help guide clinicians in triaging patients who develop pneumonitis after radiation and during ICI treatment. John Wiley & Sons, Inc. 2021-08-04 2021-10 /pmc/articles/PMC8488797/ /pubmed/34251728 http://dx.doi.org/10.1002/onco.13900 Text en © 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Lung Cancer
Chen, Xuguang
Sheikh, Khadija
Nakajima, Erica
Lin, Cheng Ting
Lee, Junghoon
Hu, Chen
Hales, Russell K.
Forde, Patrick M.
Naidoo, Jarushka
Voong, Khinh Ranh
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title_full Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title_fullStr Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title_full_unstemmed Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title_short Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
title_sort radiation versus immune checkpoint inhibitor associated pneumonitis: distinct radiologic morphologies
topic Lung Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488797/
https://www.ncbi.nlm.nih.gov/pubmed/34251728
http://dx.doi.org/10.1002/onco.13900
work_keys_str_mv AT chenxuguang radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT sheikhkhadija radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT nakajimaerica radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT linchengting radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT leejunghoon radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT huchen radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT halesrussellk radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT fordepatrickm radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT naidoojarushka radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies
AT voongkhinhranh radiationversusimmunecheckpointinhibitorassociatedpneumonitisdistinctradiologicmorphologies